CAI 2022 DMV Investor Forum Advancing Technologies to Impact the World
Our Fourth Conference
Join us on September 23rd in Washington, DC for CAI’s 2022 DMV Investor Forum! The forum will be held at the Children’s National Research and Innovation Campus and is made possible by generous support from Resonance Philanthropies of the Silicon Valley Community Foundation, Children’s National Hospital, and the US EDA Build to Scale Program. Forum speakers will include Rosemarie Truman, the Founder and CEO of CAI and Co-Founder and CEO of Ignite Social Impact, as well as winners of the Innovate Children’s Health Challenge II (ICHC II), an innovation challenge to advance biotechnology, health security, and supply chain technologies with the potential to boost children’s mental health and pandemic resiliency globally.
To attend the conference, log in to LinkedIn, and register at linkedin.com/events/6970126463555575808/.
When and Where:
The conference will be held on September 23rd from 1:30-4:30pm ET at the Children’s National Research and Innovation Campus in the Conference Theater at 7115 13th Place, NW, Washington, DC 20012.
Parking is available at 7185 13th Place, NW, Washington, DC, 20012.
Registrants will receive more information about logistics, timing, and speakers.
Founder and CEO, The Center for Advancing Innovation
Rosemarie Truman is an entrepreneur, growth strategist, distinguished corporate executive, angel investor and prolific startup catalyst. Currently, Rosemarie is the Founder and CEO of the Center for Advancing Innovation (CAI), a 501c3 non-profit which has been coined “Tinder for Startups” and “Shark Tank on Steroids.” CAI’s mission to identify breakthrough inventions and maximize their commercial potential.
Under Rosemarie’s leadership, CAI has earned numerous awards and recognition from Health and Human Services, the White House, the Federal Laboratory Consortium and more. CAI has also been featured in the Washington Post, Wired, Huffington Post, Nature, and several other publications.
Rosemarie’s specialty is growth and investment strategy, having led growth strategies for 50 of the global Fortune 100 companies in over 15 countries. The strategies that Rosemarie led have resulted in $300+ billion in “net new” top line yearly revenue and 190+ new products on the market.
Prior to launching her own firm, Rosemarie spearheaded IBM’s Innovation strategy practice globally. At IBM, she was awarded IBM’s most laudable honor, the Golden Circle Award. In addition, she has also held notable leadership roles at Booz Allen Hamilton, Oracle, PRTM, and Marsh & McLennan, where she served as VP of global strategy. Rosemarie began her career at Goldman Sachs. Her core competencies are in leadership, strategy consulting, investment banking and entrepreneurship.
In her spare time, Rosemarie also writes for Forbes and sits on company boards.
Co-Founder, Resonance Philanthropies
Sheri Sobrato Brisson, eldest daughter of John and Sue Sobrato, is passionate about working with children facing serious illnesses and their families. She is the founder of Digging Deep Project, co-author of Digging Deep: A Journal for Young People Facing Health Challenges, and creator of Shadow’s Edge — a mobile game for teens with medical conditions.
Sheri is a member of The Philanthropy Workshop, a Dame of Honor of the Knights of St. John, and an alumna of the Pipeline Fellowship. She holds a B.A. from Stanford University and an M.A. from Santa Clara University.
Chief Executive for Medical Portfolio, JPEO-CBRND, Department of Defense
Colonel Matthew G. Clark is the Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical). He is responsible for leading the medical portfolio for the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND).
COL Clark previously served as Senior Policy Advisor and Director of COVID-19 International Response Operations on the White House COVID-19 Response Team (WHCRT), after serving as the Lead Program Manager for the vaccine team in Operation Warp Speed. He was on hiatus from serving as the Director of the Office of Medical Systems under the Assistant Secretary of the Army for Acquisition, Logistics, and Technology. On the WHCRT, he led operations to move 1.2+ billion COVID-19 vaccines to 115 countries bilaterally and through: COVID-19 Vaccines Global Access, involving Gavi (The Vaccine Alliance); the World Health Organization; the United Nations Children’s Fund; the Pan American Health Organization global organizations; and the African Vaccine Acquisition Trust, via the African Union. He worked the whole-of-government vaccine response through: the U.S. Department of Health and Human Services Coordination Operation Response Element (formerly the Countermeasures Acceleration Group); the Departments of State and Defense; the U.S. Agency for International Development; the National Institutes of Health; the U.S. Food and Drug Administration; the Centers for Disease Control and Prevention; and the Federal Emergency Management Agency. The public-private team he led delivered over 534 million doses.
COL Clark previously served as Joint Product Manager for Chemical Defense Pharmaceuticals in the JPEO-CBRND. His team received a Gold-level Edison Award™ of Innovation for high-quality, rapid product development for tightly-engineered capabilities, published in four Army AL&T Magazine articles; and received MG Harry Greene Awards in 2018 and 2019. He was also the first medical officer recognized as the U.S. Army’s Product Manager of the Year in 2018. In other leadership positions around the world, he directed medical clinics and laboratories, served as Military Legislative Assistant in the U.S. House of Representatives, and as the Director of the Eisenhower Leader Development Program at the U.S. Military Academy at West Point and Columbia University.
He is a distinguished graduate of Coe College and received a PhD in behavioral and neural sciences from Rutgers University. He also has a master’s with distinction in strategic studies from the Army War College, and in 2021, received a doctorate of humane letters from Coe College. He has published two edited books, eight book chapters, and over 30 peer-reviewed and professional articles.
Vice President and Chief Innovation Officer, Children’s National Hospital
LinkedIn
https://www.linkedin.com/in/kolaleh/
As Vice President and Chief Innovation Officer, Dr. Eskandanian leads the strategic and operational management of novel product development at Children’s National, with a focus on translating pediatric innovation to patients and families. She is the Managing Director of Innovation Ventures, the commercialization arm of Children’s National, the Executive Director of the Sheikh Zayed Institute for Pediatric Surgical Innovation, and Principal Investigator of the National Capital Consortium for Pediatric Device Innovation, an FDA-funded initiative. Most recently, Dr. Eskandanian played a critical leadership role in the development of the Children’s National Research and Innovation Campus (opening in second quarter 2021), housing Children’s National Research Institute as well as JLABS @ Washington, DC and Virginia Tech as the initial anchors of the campus. Dr. Eskandanian works with a large network of small and large businesses, nonprofits, and government agencies to maximize the commercial potential of pediatric novel products. Since early 2014, over 160 pediatric medical device companies have been funded and/or received technical expertise through initiatives led by Dr. Eskandanian. Her own innovations are in the market space for decades, used by millions. Dr. Eskandanian is the lead inventor of the first-ever adverse event reporting system, initially deployed in a research academic environment. She has had leadership roles in the development of the first web-based consumer trouble-entry management system for a Fortune 100 company in the telecommunications sector. In her role in academia, she has been instrumental in securing over $100 million in peer-reviewed government funding.
Prior to joining Children’s National, Dr. Eskandanian held positions with Intelsat, Accenture, and Georgetown University. Kolaleh’s background is in mechanical engineering with a PhD in operations science and an MBA. A polyglot and avid traveler, she has lived on three continents and speaks four languages fluently.
Vice President Research Administration, Children’s National Hospital
Kerstin Hildebrandt — Vice President Research Administration, Children’s National Hospital, Children’s National Research Institute — is an accomplished and result-driven leader with over 25 years of wide ranging healthcare, capital assets development, research administration and regulatory experience. She has a proven track record of exceeding operating and financial goals leading strategic initiatives and high performance matrix teams who deliver strong quality and safety results. She possesses an excellent balance of business acumen, healthcare and research administration knowledge. Kerstin is an intuitive and practical problem-solver skilled in analyzing processes, identifying customer requirements, risk management, negotiating, and conflict resolution with a collaborative leadership style.
CEO, Sequella Inc.
Dr. Carol Nacy co-founded Sequella, Inc. in 1997 and has served as its CEO and Chairman of the Board since 1999. Prior to Sequella, Dr. Nacy served during 1997 and 1998 as Chief Scientific Officer (CSO) for Anergen, Inc. (NASDAQ: ANRG), a California company acquired by Corixa Corporation in December 1998. From 1993 through 1997, Dr. Nacy was Executive Vice President and CSO at EntreMed, Inc. (NASDAQ: ENMD) and participated in its successful initial public offering in June 1996. Previously, Dr. Nacy was Career Scientist (GS-15) at the Walter Reed Army Institute of Research, Washington, DC. Dr. Nacy currently serves on board of directors of companies and non-profit agencies.
Chair and Shareholder, Polsinelli Law Firm
Pete Thurlow is an experienced patent lawyer, focused on presenting strategies to help protect inventors, small businesses, and multinational corporations’ intellectual property rights. Pete’s practice involves the full spectrum of patent law.
Pete was the President of the New York Intellectual Property Law Association (NYIPLA) in 2018-2019, the primary intellectual property law association in New York with more than 1,000 members. Based on Pete’s extensive experience working on matters at the USPTO, he served on the USPTO’s Patent Public Advisory Committee (PPAC) from 2012 to 2018 based on an appointment from the U.S. Secretary of Commerce. The PPAC includes nine experienced patent practitioners that advise the Undersecretary of Commerce and Director of the USPTO on USPTO patent policies and procedures. The PPAC provides an annual report to the White House, U.S. Commerce Department, House and Senate Judiciary Committees, and the USPTO.
Changing the treatment paradigm for infantile hemangiomas using an established drug
https://www.arkayli.com/
Changing the treatment paradigm for infantile hemangiomas using an established drug
Delivering digital tools and diagnostics to improve infant outcomes with nutrition intelligence
https://astartemedical.com/
Delivering digital tools and diagnostics to improve infant outcomes with nutrition intelligence
Empowering every human being with both access and ownership of all personal health information
https://b1os.life/
Empowering every human being with both access and ownership of all personal health information
Creating the largest digital blockchain-encrypted repository of African clinical and genomic data
https://indygeneus.ai/
Creating the largest digital blockchain-encrypted repository of African clinical and genomic data
Establishing a wellbeing research-based preventive program to decrease mental health risks
https://www.mindtheclass.org/
Establishing a wellbeing research-based preventive program to decrease mental health risks
Reducing costs for all with a 3D printed nanomaterial for cartilage repair and regrowth
https://www.nanochon.com/
Reducing costs for all with a 3D printed nanomaterial for cartilage repair and regrowth
Making point-of-care fingerstick diagnostics for nutrition professionals to improve global health
https://www.vitascan.me/
Making point-of-care fingerstick diagnostics for nutrition professionals to improve global health
Providing online & telehealth therapy for kids, teens & families with behavioral & mental health issues
https://www.youmehealthcare.com/
Providing online & telehealth therapy for kids, teens & families with behavioral & mental health issues
